Diabetes Mellitus (DM) is characterized by the inability of the body to process sugar. Glycemic control is important in the management of diabetic patients; therefore, there is a particular concern towards the insufficient management of oral drug therapy and delayed insulin therapy initiation. The current study was made to observe the status of antidiabetic drugs' prescription pattern. This is a cross-sectional, questionnaire-based survey study, which was conducted over a period of February 2014 to May 2014 and it was carried out in Ajman. A convenient sample comprising a total of (213) diabetic participants of 18 years old and above. A self-administered bilingual questionnaire was used as a tool to collect data and the results were analyzed using Microsoft Excel. The prescribing trend was found to be monotherapy (43% Metformin, 33% Insulin and 17% Gliclazide) and (7%) of participants used a combination therapy of Metformin and Insulin. The study reflected that the prescribing trend in the enrolled participants was mainly monotherapy and among the cardiovascular complications reported that can cause major threat was hypertension. Similar other studies indicate that the compliance with medication, exercise and avoiding risk factors are very important to prevent complications.
INTRODUCTION
Diabetes is a chronic disease presented by the inability of the body to process sugar and it is a major cause of morbidity and mortality (Alberti and Zimmet, 1998; Afolayan and Sunmonu, 2010) . In the long term, uncontrolled Diabetes Mellitus leads to organ damage and is associated with microvascular and macrovascular complications (Stumvoll et al., 2005) . There are many cardiovascular complications that can cause a major threat and one of them is smoking which is associated with an increased risk of progression of chronic diabetes-related complications (Huda et al., 2010) . Glycemic control is very important in the management of diabetic patients and more effective methods to help patients follow medical regimens are needed. The management and initiation of some antidiabetic drugs are of a particular concern that's why this study is a component of a medical audit that evaluates the prescribing practice of the prescribers through patients' feedback and the current study was designed to observe the current status of the anti-diabetic drugs prescription pattern.
MATERIAL AND METHODS
This is a cross-sectional survey based study which had been conducted over a period of three months from February 2014 to May 2014 and it was carried out in Ajman, UAE.
A convenient sample was used comprising a total of (213) participants from different nationalities and Participants with diabetes (Type I or Type II), 18 years old and above, regardless of their income or educational level. A self-administered bilingual questionnaire was used as a tool to collect data from the participants. It was distributed to participants matching with the specified inclusion criteria in waiting rooms in some clinics and patient's visiting community pharmacies.
Inclusion and exclusion criteria
Diabetic patients from different nationalities; 18 years old and above regardless of their income or educational level in waiting rooms of some clinics and patients visiting community pharmacies. Participants willing to participate and understand English or Arabic and also must be a resident of Ajman only. Language barrier and participants from other emirates were not enrolled in this study. The results show that most of the participants were Arabs (45%) & the majority were educated (64%) holding a university degree, (22%) a High School degree and most of them were non-married (75%). The results show that (82%) of Male participants were smokers compared to only (3%) of female participants, also only (25%) of the participants were exercising, The majority of male participants (43%) had DM for a duration less than 5 years while the majority of females (45%) had it for 5 to 10 years, (31%) of females had hypertension along with DM compared to (29%) male.
Pre-testing and validation of the questionnaire
Prior to the study, the questionnaire was validated by subject experts for its content and relevance. Furthermore, it was field-tested on a pilot sample of 50 participants to clarify any ambiguities and to determine the reliability of the questionnaire.
Ethical considerations
Prior to the administration of the questionnaires, the intentions of the survey were explained and participants were encouraged to participate without any undue pressure. Participation was voluntary and all respondents joined in with no incentives and signed the informed consents to take part in this study. The study was approved by the institutional ethics committee. The results show that the prescribing trend of monotherapy was (43% Metformin, 33% Insulin and 17% Gliclazide) while combination therapy of insulin and Metformin represented only (7%).
Statistical analysis
The results were analyzed using Microsoft Excel. Descriptive statistics were used to summarize the data concerning the demographic characteristics. Categorical variables (such as nationality and educational level) were described by using frequency, percentages, bar chart and pie chart. The results show that the majority of participants (37.56%) had DM for 5-10 years followed by (35.21%) who had it for less than 5 years and (27.23%) for more than 10 years.
RESULTS AND DISCUSSION
The results show that the majority of participants (37.56%) had DM for 5-10 years followed by (35.21%) who had it for less than 5 years and (27.23%) for more than 10 years. In the current study, most of male participants (43%) were observed to have less than 5 years duration of diabetes compared to (29%) of female respondents, while most of the female respondents (45%) reported a duration of diabetes from 5 to 10 years compared to (28%) of males (Table 2) (Figure 2 ). Among the Cardiovascular complications which can cause major threat, (30%) of the respondents reported the presence of hypertension as well and (82%) of male respondents were smokers compared to (3%) in females (Figure 1) .
It was observed in the current study that only (25%) of respondents followed their physician's daily exercise advice which is significantly higher than a study conducted in Egypt in 2010 in which nearly 0% followed daily exercise advices (Ibrahim et al., 2010) . In contrast a study conducted in Nepal in 2013 showed a higher response in which about 50% followed physicians' daily exercise advices (Parajuli et al., 2014 ). In the current study, the prescribing trend was found to be monotherapy, 43% Metformin, 33% Insulin and 17% Gliclazide (Table 3 ). The most commonly used antidiabetic drug (monotherapy) was Metformin in the present study. Metformin has beneficial effects on several cardiovascular risk factors and therefore it's widely regarded as the drug of choice for most patients with diabetes (Krentz et al., 2005) . This result was in line with other studies which had similar observations such as (Sultana et al., 2010; Yurgin et al., 2007) . This result contrasts the reports of some other studies done in India (Xavier et al., 1999; Lau et al., 1996) which reported that Glibenclamide was the most commonly prescribed anti-diabetic drug. If the glycaemic targets can't be achieved with maximum doses of Oral Antidiabetic Drugs (OADs) as in the traditional management therapy, the American Diabetes Association (ADA) recommended the initiation of insulin therapy for the treatment of type II diabetes if the target HbA1c of (7%) is not achieved within three months treatment with Metformin along with lifestyle interventions (Nathan et al., 2009) .
In the present study (33%) have used Insulin as monotherapy which is much higher than a previously reported study (11.5%) in New Delhi, India (Sultana et al., 2010) . This could be due to presence of some comorbid conditions such as hypertension, etc. or due to uncontrolled diabetes and resistance to oral antidiabetic drugs. Starting intensive insulin therapy early in the course of type II diabetes or immediately after a diet and exercise regimen failure is supported by many studies in order to protect the remaining ß-cell function and improve the glycaemic control (Campbell and White, 2002) .
It was also observed that (7%) of the study participants used a combination therapy of Metformin and Insulin. It is known that the effectiveness of insulin either as monotherapy or in combination with OAD is well established. A treatment with a combination of insulin and metformin alone proved more costeffective than triple OAD therapy of sulfonylurea, metformin, and thiazolidinedione (Fonseca, 2006) .
CONCLUSION
The study reflected that the prescribing trend in the enrolled participants was found to be mainly monotherapy and among the cardiovascular complications reported that can cause major threat was hypertension. Similar other studies indicate that the compliance with medication, exercise and avoiding risk factors are very important to prevent complications.
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